arrow_back Trending Legislation
Share share

End Drug Price Gouging: Lower Costs for All Americans

This bill aims to lower prescription drug prices by setting maximum prices based on international rates. This means that medications for individuals in federal programs, as well as all other citizens, will not be able to exceed these set limits. Manufacturers who do not comply will face penalties, with collected funds directed towards drug research.
Key points
Establishes maximum prices for prescription drugs to make them more affordable for citizens.
Drug prices will be based on the lowest retail prices in selected countries like Canada, Germany, or the UK.
New rules apply to individuals in Medicare, Medicaid, TRICARE, veteran and federal employee programs, and all other citizens, including the uninsured.
Drug manufacturers selling above the set price will face significant penalties, with funds used for new drug development.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
End Price Gouging for Medications Act
Print number: S 1753
Sponsor: Sen. Merkley, Jeff [D-OR]
Process start date: 2025-05-14
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about End Drug Price Gouging: Lower Costs for All Americans

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 1753.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-05-14.

What are the main provisions?

Key points include:

  • Establishes maximum prices for prescription drugs to make them more affordable for citizens.
  • Drug prices will be based on the lowest retail prices in selected countries like Canada, Germany, or the UK.
  • New rules apply to individuals in Medicare, Medicaid, TRICARE, veteran and federal employee programs, and all other citizens, including the uninsured.
  • Drug manufacturers selling above the set price will face significant penalties, with funds used for new drug development.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Merkley, Jeff [D-OR].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

Analysis and Potential Impact of S 1753

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health